Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015

Print

Topics - Drug Development


Refine by Date:
From: To:
Published May 27, 2015
Bedford to bolster branding and marketing ops post Harlan acquisition Read More »
Published May 27, 2015
Aims to simplify patient randomization and clinical supply management Read More »
Published May 27, 2015
Provides access to Quintiles’ processes and platforms Read More »
Published May 27, 2015
To explore late-stage assets in combination with Imbruvica Read More »
Published May 27, 2015
Believes events of suicidal ideation and behavior likely to restrict labeling Read More »
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 21, 2015
Biomay to apply VTU Pichia strains for the production of recombinant allergens Read More »
Published May 20, 2015
Will use Achillion assets to develop pan-genotypic oral regimen for HCV Read More »
Published May 19, 2015
Will evaluate combinations of Advaxis’s Lm-LLO immunotherapy technology and Sorrento’s immunomodulatory antibodies Read More »
Published May 18, 2015
Phase I drug demonstrates oral bioavailability, target inhibition, safety and tolerability Read More »
Published May 18, 2015
Aims to target underlying causes of MS disease progression Read More »
Published May 15, 2015
Publishes results from Enabled-First-in-Human program conducted for the Janssen WAVE Early Development unit. Read More »
Published May 14, 2015
Biologics Services revenues up 75% in the quarter Read More »
Published May 14, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On